# Puma Biotechnology, Inc.: Form 8-K, filed Jun 15, 2023

- Company: [Puma Biotechnology, Inc.](/companies/pbyi.md) (CIK 1401667)
- Form: 8-K
- Filed: 2023-06-15
- Accepted by EDGAR: Jun 15, 2023, 17:10 ET
- Period: 2023-06-13
- Accession: 0001437749-23-017581
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1401667/000143774923017581/pbyi20230615_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1401667/000143774923017581/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1401667/000143774923017581/pbyi20230615_8k.htm

Filed Jun 15, 2023.
Source: SEC EDGAR, the filing index for accession 0001437749-23-017581. Last ingested by Listed: Nov 5, 2026, 17:46 ET. No prices; not investment advice.